Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heide Wissel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Experimental Lung Research|November 18, 2009
Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injuryFlorian Guthmann, Heide Wissel, Bernd Rüstow
Pediatric Research|July 22, 2006
Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitroHeide Wissel, Wolfram Burkhardt, Jan Rupp, et al.
Biochimica Et Biophysica Acta|March 22, 2005
Contact of Chlamydophila pneumoniae with type II cell triggers activation of calcium-mediated NF-kappa B pathwayHeide Wissel, Torsten Müller, Mario Rüdiger, et al.
Respiratory Research|June 7, 2005
Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytesHeide Wissel, Christian Schulz, Petra Koehne, et al.
American Journal of Respiratory Cell and Molecular Biology|July 2, 2002
HDL-holoparticle uptake by alveolar type II cells: effect of vitamin E statusIngrid Kolleck, Heide Wissel, Florian Guthmann, et al.
American Journal of Respiratory Cell and Molecular Biology|April 5, 2003
Chlamydia pneumoniae affect surfactant trafficking and secretion due to changes of type II cell cytoskeletonHeide Wissel, Christian Schulz, Mario Rüdiger, et al.
Respiratory Research|January 25, 2005
Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cellsFlorian Guthmann, Heide Wissel, Christian Schachtrup, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 25, 2008
Intratracheal perfluorocarbons diminish LPS-induced increase in systemic TNF-alphaWolfram Burkhardt, Petra Koehne, Heide Wissel, et al.
Critical Care Medicine|April 12, 2003
Perfluorocarbons are taken up by isolated type II pneumocytes and influence its lipid synthesis and secretionMario Rüdiger, Heide Wissel, Matthias Ochs, et al.
Biochimica Et Biophysica Acta|May 29, 2004
Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: contribution of caveolin-1 and PPARgammaFlorian Guthmann, Christian Schachtrup, Angelika Tölle, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Experimental Lung Research|November 18, 2009
Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injuryFlorian Guthmann, Heide Wissel, Bernd Rüstow
Pediatric Research|July 22, 2006
Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitroHeide Wissel, Wolfram Burkhardt, Jan Rupp, et al.
Biochimica Et Biophysica Acta|March 22, 2005
Contact of Chlamydophila pneumoniae with type II cell triggers activation of calcium-mediated NF-kappa B pathwayHeide Wissel, Torsten Müller, Mario Rüdiger, et al.
Respiratory Research|June 7, 2005
Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytesHeide Wissel, Christian Schulz, Petra Koehne, et al.
American Journal of Respiratory Cell and Molecular Biology|July 2, 2002
HDL-holoparticle uptake by alveolar type II cells: effect of vitamin E statusIngrid Kolleck, Heide Wissel, Florian Guthmann, et al.
American Journal of Respiratory Cell and Molecular Biology|April 5, 2003
Chlamydia pneumoniae affect surfactant trafficking and secretion due to changes of type II cell cytoskeletonHeide Wissel, Christian Schulz, Mario Rüdiger, et al.
Respiratory Research|January 25, 2005
Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cellsFlorian Guthmann, Heide Wissel, Christian Schachtrup, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 25, 2008
Intratracheal perfluorocarbons diminish LPS-induced increase in systemic TNF-alphaWolfram Burkhardt, Petra Koehne, Heide Wissel, et al.
Critical Care Medicine|April 12, 2003
Perfluorocarbons are taken up by isolated type II pneumocytes and influence its lipid synthesis and secretionMario Rüdiger, Heide Wissel, Matthias Ochs, et al.
Biochimica Et Biophysica Acta|May 29, 2004
Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: contribution of caveolin-1 and PPARgammaFlorian Guthmann, Christian Schachtrup, Angelika Tölle, et al.
Pageof 1